Skip to Content

Synthetic Conjugated Estrogen

Last Updated: August 5, 2016
Status: Current

Products Affected - Description

Enjuvia tablet, Teva
0.3 mg, 100 count (NDC 51285-0406-02) - discontinued
0.45 mg, 100 count (NDC 51285-0407-02) - discontinued
0.625 mg, 100 count (NDC 51285-0408-02 - discontinued
0.9 mg, 100 count (NDC 51285-0409-02) - discontinued

1.25 mg, 100 count (NDC 51285-0410-02) - discontinued

Reason for the Shortage

  • Teva discontinued Cenestin in late-August 2014.
  • Premarin is not affected by this shortage.
  • Teva discontinued Enjuvia in mid-2106.

Available Products

There are no presentations available.

Estimated Resupply Dates

Teva has discontinued all Enjuvia presentations.

Related Shortages

Updated

August 5, May 9, February 5, 2016; December 1, September 3, June 15, April 20 and 15, February 19, 2015; November 25, August 28, May 29, April 10, March 6, 2014, University of Utah, Drug Information Service. Copyright 2016, Drug Information Service, University of Utah, Salt Lake City, UT.

Hide